TUMOR MUTATIONAL BURDEN (TMB) IS A POTENTIAL PREDICTOR OF RESPONSE TO IMMUNE CHECKPOINT INHIBITORS (ICI) IN METASTATIC TRIPLE-NEGATIVE BREAST CANCER (MTNBC)
Downloads
Download data is not yet available.
Downloads
Published
2019-09-29
How to Cite
Barroso-Sousa, R., Tyekucheva, S., Exman, P., Umeton, R., Hodi, F. S., Winer, E. P., … Tolaney, S. M. (2019). TUMOR MUTATIONAL BURDEN (TMB) IS A POTENTIAL PREDICTOR OF RESPONSE TO IMMUNE CHECKPOINT INHIBITORS (ICI) IN METASTATIC TRIPLE-NEGATIVE BREAST CANCER (MTNBC). Mastology, 29(3), 5. Retrieved from https://revistamastology.emnuvens.com.br/revista/article/view/728
Issue
Section
Geral
License
Copyright (c) 2019 Romualdo Barroso-Sousa, Svitlana Tyekucheva, Pedro Exman, Renato Umeton, F. Stephen Hodi, Eric P. Winer, Nancy U Lin, Sara M. Tolaney
This work is licensed under a Creative Commons Attribution 4.0 International License.